Robot-assisted Endoscope Market Size & Growth Forecast 2027–2036, By Segments (End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Robot-assisted Endoscope Market size was more than USD 1.8 billion in 2026 and is set to grow at a 7.79% CAGR between 2027 and 2036, crossing USD 3.81 billion by 2036. The industry revenue for 2027 is assessed at USD 1.92 billion.
Get more details on this report
Request Free Sample ReportRobot-assisted Endoscope Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 44.32% share due to early adoption of robotic endoscopy, strong hospital infrastructure, supportive reimbursement systems, and integration of minimally invasive technologies into workflows.
- Asia Pacific is growing at 9.38% CAGR, driven by healthcare modernization, rising investment in advanced endoscopy platforms, and expanding demand for minimally invasive diagnostic and therapeutic procedures.
Segment Momentum
- Outpatient Facilities held a 55.98% share in 2026 because robot-assisted endoscope systems align well with efficient outpatient workflows, shorter patient stays, and optimized resource utilization.
- Growth is driven by increasing preference for minimally invasive procedures that can be completed without extended hospitalization, reinforcing demand for streamlined treatment delivery in outpatient environments.
Market Expansion Drivers
- Rising gastrointestinal and cancer prevalence increasing demand for precision robotic endoscopic procedures.
- Advancements in robotic visualization systems enhancing minimally invasive diagnostic and surgical outcomes.
- Expanding hospital investments in minimally invasive surgical infrastructure supporting robotic endoscopy adoption.
Leading Market Participants
- Top companies in the robot-assisted endoscope market include Intuitive Surgical, Inc. (United States), Medtronic plc (Ireland), Johnson & Johnson (United States), Stryker Corporation (United States), Boston Scientific Corporation (United States), Asensus Surgical, Inc. (United States), Brainlab AG (Germany), Olympus Corporation (Japan), Karl Storz SE & Co. KG (Germany), Smith & Nephew plc (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.8 billion
- 2027 Estimated Market Size: USD 1.92 billion.
- Projected Market Size: USD 3.81 billion by 2036
- Growth Forecast: 7.79% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Outpatient Facilities (End-use)
- Emerging Opportunity Segment: Outpatient Facilities (End-use)
Market Growth Drivers and Industry Trends
Rising gastrointestinal and cancer prevalence increasing demand for precision robotic endoscopic procedures
Rising gastrointestinal and cancer prevalence will drive the robot-assisted endoscope market as healthcare systems seek more precise technologies for diagnosing and treating complex conditions. Robotic endoscopic platforms can provide enhanced control, maneuverability, and visualization during procedures involving anatomically challenging areas, supporting clinicians in performing minimally invasive interventions. Increasing demand for early detection and targeted treatment of gastrointestinal disorders and cancers is also expanding the range of endoscopic procedures requiring greater procedural precision. The integration of robotic assistance into these workflows can help clinicians manage delicate examinations and interventions with improved instrument control.
Advancements in robotic visualization systems enhancing minimally invasive diagnostic and surgical outcomes
Advancements in robotic visualization systems will propel the robot-assisted endoscope market by improving clinicians' ability to observe and navigate anatomical structures during minimally invasive procedures. Enhanced imaging, articulation, depth perception, and instrument positioning can provide greater procedural control compared with conventional endoscopic approaches. These capabilities are particularly valuable when procedures require accurate navigation through complex anatomical pathways or precise manipulation of tissue. Improvements in visualization technology are also strengthening the integration of robotic systems into diagnostic and therapeutic endoscopy, where clear anatomical assessment is essential.
Expanding hospital investments in minimally invasive surgical infrastructure supporting robotic endoscopy adoption
Expanding hospital investments in minimally invasive surgical infrastructure will boost the robot-assisted endoscope market as healthcare providers modernize operating rooms and procedure suites with advanced technology. Hospitals are increasingly evaluating robotic platforms as part of broader efforts to improve surgical capabilities, support efficient procedural workflows, and expand access to minimally invasive interventions. Investment in compatible imaging, navigation, robotic equipment, and specialized staff training can create the infrastructure required for wider robotic endoscopy deployment. As hospitals strengthen their minimally invasive treatment capabilities, robotic endoscopic systems can become integrated into broader surgical technology ecosystems.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising gastrointestinal and cancer prevalence increasing demand for precision robotic endoscopic procedures | 2.00% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in robotic visualization systems enhancing minimally invasive diagnostic and surgical outcomes | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Expanding hospital investments in minimally invasive surgical infrastructure supporting robotic endoscopy adoption | 1.40% | Moderate | Asia Pacific, Latin America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The robot-assisted endoscope market was led by North America, which held a 44.32% share in 2026, reflecting the region's mature minimally invasive surgery ecosystem and high adoption of advanced robotic technologies. Hospitals and surgical centers are increasingly incorporating robotic assistance to improve visualization, procedural precision, and physician control during complex interventions. Strong healthcare infrastructure, specialist expertise, and continued investment in surgical technology are supporting the integration of robot-assisted endoscopic platforms into advanced clinical settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing region as hospitals modernize surgical infrastructure and demand for minimally invasive procedures increases. Rising healthcare investment and expanding access to robotic technologies are enabling more medical institutions to adopt advanced endoscopic systems. Growing clinical expertise, improvements in hospital capabilities, and increasing patient preference for less invasive treatment approaches are expected to encourage further adoption throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Workflow Optimization FocusGermany emphasizes robot-assisted endoscopy solutions that integrate seamlessly with established surgical and imaging infrastructure. Healthcare providers in Germany prioritize systems that improve procedural accuracy while supporting efficient operating room utilization and standardized clinical performance.
France 🇫🇷
Minimally Invasive EnhancementFrance promotes robot-assisted endoscopy as part of broader efforts to improve minimally invasive treatment pathways. Clinical centers in France assess robotic technologies based on procedural reliability, physician usability, and their contribution to improving diagnostic and therapeutic precision.
Italy 🇮🇹
Hospital Technology ModernizationItaly is gradually expanding investment in robot-assisted endoscope platforms within specialized healthcare centers. Hospitals in Italy focus on technologies that strengthen minimally invasive capabilities while supporting clinician training and more efficient endoscopic interventions.
Japan 🇯🇵
Precision Robotic ImagingJapan continues advancing robot-assisted endoscope technologies through strong engineering capabilities and demand for minimally invasive care. Hospitals in Japan focus on systems that enhance maneuverability, imaging precision, and clinician confidence during technically demanding procedures.
South Korea 🇰🇷
Digital Procedure IntegrationSouth Korea is adopting robot-assisted endoscope platforms alongside digitally connected hospital environments. Healthcare providers in South Korea increasingly value systems that combine robotic navigation with advanced visualization to improve procedural consistency and patient care efficiency.
United States 🇺🇸
Intelligent Endoscopy DeploymentThe U.S. robot-assisted endoscope market is driven by healthcare systems investing in precision diagnostics and minimally invasive interventions. Hospitals in the U.S. increasingly evaluate robotic platforms that enhance physician control, visualization, and workflow efficiency during complex endoscopic procedures.
Segment Leadership and Growth Trends
Robot-assisted Endoscope Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Outpatient Facilities (Largest & Fastest-Growing Segment)
Outpatient facilities led the robot-assisted endoscope market, accounting for a 55.98% share in 2026, while also representing the fastest-growing end-use segment. Their strong position is supported by the increasing shift toward minimally invasive procedures that can be performed without prolonged hospital stays. Robot-assisted endoscopic technologies can enhance visualization, instrument control, procedural precision, and physician ergonomics, making them well suited to outpatient environments where efficient clinical workflows and shorter recovery periods are important. The expansion of ambulatory care models is further encouraging healthcare providers to adopt advanced procedural technologies that can support complex interventions while maintaining operational efficiency. In addition, improvements in compact robotic platforms, imaging capabilities, and endoscopic instruments are making these systems increasingly adaptable to outpatient settings. The combination of growing preference for less invasive interventions, greater emphasis on efficient patient throughput, and continued modernization of outpatient procedural infrastructure is strengthening demand for robot-assisted endoscopy in these facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Outpatient Facilities | Outpatient Facilities | Outpatient Facilities |
Competitive Landscape and Market Positioning
Leading companies in the robot-assisted endoscope market:
1. Intuitive Surgical Inc. (United States)
2. Medtronic plc (Ireland)
3. Johnson & Johnson (United States)
4. Stryker Corporation (United States)
5. Boston Scientific Corporation (United States)
6. Asensus Surgical Inc. (United States)
7. Brainlab AG (Germany)
8. Olympus Corporation (Japan)
9. Karl Storz SE & Co. KG (Germany)
10. Smith & Nephew plc (United Kingdom)
The robot-assisted endoscope market is rapidly evolving through the integration of robotics, artificial intelligence, and advanced imaging technologies. Companies are developing precision-guided endoscopic systems that improve maneuverability, visualization, and procedural accuracy in minimally invasive interventions. Increased investment in robotic innovation and intelligent navigation capabilities is also accelerating the commercialization of next-generation endoscopic platforms.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Johnson & Johnson (United States) | |||||||
| Stryker Corporation (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Asensus Surgical Inc. (United States) | |||||||
| Brainlab AG (Germany) | |||||||
| Olympus Corporation (Japan) | |||||||
| Karl Storz SE & Co. KG (Germany) | |||||||
| Smith & Nephew plc (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| EndoQuest Robotics | May-26 | EndoQuest Robotics successfully completed procedures at Baylor St. Luke's Medical Center as part of the pivotal PARADIGM multicenter clinical trial. The study evaluates the safety and effectiveness of the Endoluminal Surgical (ELS) System in robotic-assisted endoscopic submucosal dissection (ESD), marking a critical step in building the clinical evidence required for future FDA regulatory authorization. |
| EndoQuest Robotics | Jan-26 | The U.S. FDA approved the final stage of EndoQuest Robotics' PARADIGM pivotal trial, which evaluates the Endoluminal Surgical (ELS) System for robotic-assisted endoscopic submucosal dissection. This regulatory milestone allows the company to conclude subject enrollment and proceed toward a De Novo classification request, advancing the path for the platform’s potential commercial entry into the U.S. market. |
| EndoQuest Robotics | Jan-26 | EndoQuest Robotics entered a strategic collaboration with NVIDIA to integrate AI-powered vision and precision capabilities into its endoluminal robotic surgical platform. By leveraging the NVIDIA IGX Thor and Holoscan platforms, EndoQuest aims to enhance real-time data processing and surgical guidance, strengthening the technological competitive positioning of its ELS system in the global market. |
| EndoQuest Robotics | Sep-25 | EndoQuest Robotics successfully advanced its PARADIGM clinical trial with the completion of procedures at AdventHealth Orlando. These clinical milestones provide essential real-world performance data for the ELS system, demonstrating its ability to facilitate complex, minimally invasive endoluminal interventions and underscoring the company’s progress in establishing a new clinical category for robotic-assisted gastrointestinal surgery. |
| EndoQuest Robotics | Jul-25 | EndoQuest Robotics completed a Series D-2 funding round led by Crescent Enterprises. The capital infusion supports the ongoing clinical development and regulatory activities for the ELS platform, providing the financial resources necessary to navigate the final stages of the PARADIGM pivotal trial and prepare for the anticipated commercialization of its endoluminal robotic surgical technology. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Robot-assisted Endoscope Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procedure Type | Diagnostic Endoscopy, Therapeutic Endoscopy, Surgical Endoscopy, Interventional Endoscopy |
| Clinical Specialty | Gastroenterology, Urology, Gynecology, Pulmonology, Otolaryngology, Other Specialties |
| Purchasing Model | Direct Capital Purchase, Leasing, Rental, Procedure-based/Managed Service Model |
Robot-assisted Endoscope Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Procedure Volume Opportunity Assessment |
|
| Installed Base and Replacement Opportunity Analysis |
|
| Clinical Workflow Integration Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the robot-assisted endoscope market?
How much is the robot-assisted endoscope industry expected to grow by 2036?
How are hospital investments in minimally invasive infrastructure supporting the robot-assisted endoscope market?
Why are robotic visualization advancements influencing purchasing decisions in the robot-assisted endoscope market?
Why do Outpatient Facilities lead the robot-assisted endoscope market?
What is supporting the continued growth of Outpatient Facilities in the robot-assisted endoscope market?
What factors support North America’s leadership in robot-assisted endoscopy?
What is driving Asia Pacific’s growth in robot-assisted endoscope systems?
Who are the leading players in the robot-assisted endoscope landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization